- Home
- TRST vs MAZE Comparison
TRST vs MAZE Comparison
Compare TRST & MAZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRST
- MAZE
- Stock Information
- Founded
- TRST 1902
- MAZE 2018
- Country
- TRST United States
- MAZE United States
- Employees
- TRST N/A
- MAZE N/A
- Industry
- TRST Major Banks
- MAZE
- Sector
- TRST Finance
- MAZE
- Exchange
- TRST Nasdaq
- MAZE NYSE
- Market Cap
- TRST 624.8M
- MAZE 523.1M
- IPO Year
- TRST N/A
- MAZE 2025
- Fundamental
- Price
- TRST $28.52
- MAZE $8.41
- Analyst Decision
- TRST
- MAZE Strong Buy
- Analyst Count
- TRST 0
- MAZE 3
- Target Price
- TRST N/A
- MAZE $25.67
- AVG Volume (30 Days)
- TRST 106.4K
- MAZE 351.5K
- Earning Date
- TRST 04-21-2025
- MAZE 01-01-0001
- Dividend Yield
- TRST 5.04%
- MAZE N/A
- EPS Growth
- TRST N/A
- MAZE N/A
- EPS
- TRST 2.57
- MAZE 1.25
- Revenue
- TRST $169,773,000.00
- MAZE $167,500,000.00
- Revenue This Year
- TRST $13.13
- MAZE N/A
- Revenue Next Year
- TRST N/A
- MAZE N/A
- P/E Ratio
- TRST $11.08
- MAZE $6.54
- Revenue Growth
- TRST N/A
- MAZE N/A
- 52 Week Low
- TRST $25.85
- MAZE $6.71
- 52 Week High
- TRST $38.89
- MAZE $17.00
- Technical
- Relative Strength Index (RSI)
- TRST 41.22
- MAZE N/A
- Support Level
- TRST $27.18
- MAZE N/A
- Resistance Level
- TRST $29.27
- MAZE N/A
- Average True Range (ATR)
- TRST 1.27
- MAZE 0.00
- MACD
- TRST -0.00
- MAZE 0.00
- Stochastic Oscillator
- TRST 37.85
- MAZE 0.00
About TRST TrustCo Bank Corp NY
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The Company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey and Vermont.
About MAZE MAZE THERAPEUTICS INC
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.